Trial Profile
Okayama prospective oBservational study of the Effect by Sitagliptin on obesE type2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2015
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- Acronyms OBESE
- 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 05 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 20 Mar 2012 Planned End Date changed from 1 Sep 2013 to 1 Mar 2014 as reported by University Hospital Medical Information Network - Japan.